Mu, F



SignUp
(to Register)

Login
User Name
Password

Forgot Password?

About Fangping Mu (Los Alamos National Laboratory)
Fangping Mu, after completing an MSc in Chemical Engineering from Tsinghua University, China, finished his PhD in Chemical Engineering at Purdue University, Lafayette, Indiana. In 2005, he joined the Los Alamos National Laboratory, where he is currently a scientist in the Theoretical Biology and Biophysics Group, Theoretical Division. He has expertise in metabolomics modeling, drug metabolism and computational chemistry. He has applied varieties of chemoinformatics and bioinformatics tools for different metabolomics problems, such as novel metabolic reaction identification and flux analysis. Currently, he is working on biotransformation reaction prediction of xenobiotic compounds in mammals.

Abstract
Computational Xenobiotics Metabolism Prediction System

Fangping Mu (Theoretical Biology and Biophysics, Theoretical Division, Los Alamos National Laboratory, Los Alamos, NM)

Biotransformation is the process whereby a substance, usually a foreign compound (xenobiotic), is chemically transformed in the body to form a metabolite or a variety of metabolites. Chemical transformations can activate a xenobiotic rendering it toxic, or can alter a xenobiotic to a nontoxic species. The metabolism of xenobiotics is divided into phase-I and phase-II reactions, which sometimes, but not always, occur sequentially. Xenobiotic metabolism is accomplished by a limited number of enzymes that exhibit broad substrate specificities. These enzymes conduct limited types of biotransformations. The majority of Phase-I reactions occur via oxidation, including aromatic and alphatic hydroxylation, N- and O-dealkylation, deamination, and nitrogen and sulfur oxidations. Phase-I reduction reactions include nitro reductions to amines and dehalogenation, as well as the major hydrolysis reactions of esters and epoxides. In phase-II glucuronidation and sulfation are the major biotransformations. Other Phase-II reactions include acetylation, amino acid conjugation, glutathione conjugation, and methylation.

Expert systems represent the state-of-the-art xenobiotics metabolism prediction systems. These systems are rule-based systems designed to identify functional group transformations that occur in known reactions and then by generalizing, to formulate reaction rules for global application. These rules can provide reasonable prediction of all possible metabolite formation. However, they commonly predict many more metabolites than that are observed experimentally. Ranking the possibility of metabolite formation is still not consistently available.

To overcome the significant number of false-positives in rule-based systems for metabolism prediction, we investigated machine-learning technology for xenobiotics metabolism prediction. We collected human xenobiotic reactions from MDL’s Metabolite database and classified reactions according to rules based on functional group biotransformations. For each reaction rule, the reaction center can be well defined, and is represented as a molecular substructure pattern using SMARTs, which is a language for describing molecular patterns. Using the SMARTS patterns, we identified potential reaction centers for each reaction class using the identified metabolites in MDL’s Metabolite database. Each set of potential reaction centers was divided into negative and positive examples. More than 23 atomic properties were used to model the topological, geometrical, electronic and steric environment of the atoms in the molecule, and more than 42 molecular properties were used to model the shape, surface, energy, and charge distribution of the molecule. Support Vector Machines were used to separate the positive and negative examples for each reaction class. Totally 36 biotransformations have been modeled. Results show that the overall sensitivity and specificity of classifiers is around 87%. Prediction of metabolism from this method can enhance the accuracy to rank the possibility of metabolite formation.

News and Announcements
Featured Panel Discussion
Personalised Medicine: Safety and Efficacy Concerns Discussed as a Case Study
Drug Discovery Workshop
Drug Discovery Design Methods
Oxford, 26-30 July 2010
Predictive ADME & Toxicology
Oxford, 2-6 August 2010
InnovationWell Workshop
Collaboration Forum
Philadelphia, 12 October 2009
InterAction Meetings 2009
Innovation in Life Science & Healthcare Research & Product Developement
Philadelphia, 13-16 October 2009
Knowledge Management Training
Certified Knowledge Manager,
19-23 April 2010
» Download Training Program Brochure
Virtual Proceedings for Members
» Integrating Knowledge in the Life Science Product Life Cycle
» Drug Safety Knowledge Management
Featured Talks for Visitors
Knowledge Management in Drug Safety - Sidney N Kahn, PvRM
Building the Drug Safety Body of Knowledge - Jim Averback, LSIP
The Ferryman Blog
KM & Community news
Sponsors

© Copyright 2004-2009 Colayer 
Colayer